Correction: ciardiello et al. biomarker-guided anti-egfr rechallenge therapy in metastatic colorectal cancer. cancers 2021, 13,

HIGHLIGHTS

  • who: Davide Ciardiello and collaborators from the Vanvitelli, Naples, ItalyHebron University have published the article: Correction: Ciardiello et al. Biomarker-Guided Anti-EGFR Rechallenge Therapy in Metastatic Colorectal Cancer. Cancers 2021, 13,, in the Journal: Cancers 2022, 14, 3900. of 27/05/2021

SUMMARY

    Received CRICKET Prospective Irinotecan + Cetuximab Accepted: 12 May 2022 CRICKET (RAS ctDNA WT) Prospective Irinotecan + Cetuximab CRICKET (RAS ctDNA MUT) Prospective Irinotecan + Cetuximab Sunakawa Y et_al, 2020 Prospective Irinotecan + anti-EGFR published maps and institutional affil- Sunakawa Y et_al, 2020 (RAS ctDNA WT) Prospective Irinotecan + anti-EGFR iations. Sunakawa . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?